Market Tracker

07/31 10:01pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

23.34
Delayed Data
As of Jul 31
 +0.21 / +0.91%
Today’s Change
7.51
Today|||52-Week Range
25.25
+141.87%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close23.13
Today’s open23.41
Day’s range22.90 - 23.53
Volume904,771
Average volume (3 months)1,347,403
Market cap$3.0B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+14.20%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book72.08

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+1.47+2.06%
RDUSRadius Health Inc+3.08+4.09%
NVAXNovavax Inc-0.05-0.41%
OPHTOphthotech Corp+0.50+0.74%
Data as of 4:14pm ET, 07/31/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts